These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23093165)

  • 1. Empirical evaluation of very large treatment effects of medical interventions.
    Pereira TV; Horwitz RI; Ioannidis JP
    JAMA; 2012 Oct; 308(16):1676-84. PubMed ID: 23093165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment.
    Nagendran M; Pereira TV; Kiew G; Altman DG; Maruthappu M; Ioannidis JP; McCulloch P
    BMJ; 2016 Oct; 355():i5432. PubMed ID: 27789483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
    LeLorier J; Grégoire G; Benhaddad A; Lapierre J; Derderian F
    N Engl J Med; 1997 Aug; 337(8):536-42. PubMed ID: 9262498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects.
    Pereira TV; Ioannidis JP
    J Clin Epidemiol; 2011 Oct; 64(10):1060-9. PubMed ID: 21454050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses.
    Wallach JD; Sullivan PG; Trepanowski JF; Steyerberg EW; Ioannidis JP
    BMJ; 2016 Nov; 355():i5826. PubMed ID: 27884869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?
    Als-Nielsen B; Chen W; Gluud C; Kjaergard LL
    JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for treating femoral shaft fractures in children and adolescents.
    Madhuri V; Dutt V; Gahukamble AD; Tharyan P
    Evid Based Child Health; 2014 Dec; 9(4):753-826. PubMed ID: 25504970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time.
    Trikalinos TA; Churchill R; Ferri M; Leucht S; Tuunainen A; Wahlbeck K; Ioannidis JP;
    J Clin Epidemiol; 2004 Nov; 57(11):1124-30. PubMed ID: 15612138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey.
    Hemkens LG; Contopoulos-Ioannidis DG; Ioannidis JP
    BMJ; 2016 Feb; 352():i493. PubMed ID: 26858277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large trials vs meta-analysis of smaller trials: how do their results compare?
    Cappelleri JC; Ioannidis JP; Schmid CH; de Ferranti SD; Aubert M; Chalmers TC; Lau J
    JAMA; 1996 Oct 23-30; 276(16):1332-8. PubMed ID: 8861993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative rates of harms in randomized trials from more developed versus less developed countries may be different.
    Contopoulos-Ioannidis D; Tseretopoulou X; Ancker M; Walterspiel JN; Panagiotou OA; Maldonado Y; Ioannidis JP
    J Clin Epidemiol; 2016 Oct; 78():10-21. PubMed ID: 27063207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How often does an individual trial agree with its corresponding meta-analysis? A meta-epidemiologic study.
    Tam WW; Tang JL; Di MY; Tsoi KK
    PLoS One; 2014; 9(12):e113994. PubMed ID: 25474198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of evidence of treatment effects in randomized and nonrandomized studies.
    Ioannidis JP; Haidich AB; Pappa M; Pantazis N; Kokori SI; Tektonidou MG; Contopoulos-Ioannidis DG; Lau J
    JAMA; 2001 Aug; 286(7):821-30. PubMed ID: 11497536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses.
    Engels EA; Schmid CH; Terrin N; Olkin I; Lau J
    Stat Med; 2000 Jul; 19(13):1707-28. PubMed ID: 10861773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment.
    Panagiotou OA; Contopoulos-Ioannidis DG; Ioannidis JP
    BMJ; 2013 Feb; 346():f707. PubMed ID: 23403829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most recommended medical interventions reach P < 0.005 for their primary outcomes in meta-analyses.
    Koletsi D; Solmi M; Pandis N; Fleming PS; Correll CU; Ioannidis JPA
    Int J Epidemiol; 2020 Jun; 49(3):885-893. PubMed ID: 31764988
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.